GANIRELIX NEWS HIGHLIGHTS Media Articles Related to Ganirelix
Use Of Biased Language And Inaccurate Data About Male Factor Infertility On Fertility Clinic Websites In The USA Source: Fertility News From Medical News Today [2008.11.24]
Is Socioeconomic Status Associated With Higher Infertility Costs? Source: Fertility News From Medical News Today [2008.11.24]
Expert Warns Size Zero Trend Can Cause Infertility Source: Fertility News From Medical News Today [2008.11.07]
Health Tip: Help Prevent Infertility Source: MedicineNet Alcohol Abuse and Alcoholism Specialty [2008.11.03]
Study: Infertility Treatments No Help Source: MedicineNet Polycystic Ovary Specialty [2008.08.08]
Published Studies Related to Ganirelix
Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial. [2006.03]
LH suppression following different low doses of the GnRH antagonist ganirelix in polycystic ovary syndrome. [2005.12]
Prospective, randomized trial comparing cetrorelix acetate and ganirelix acetate in a programmed, flexible protocol for premature luteinizing hormone surge prevention in assisted reproductive technologies. [2005.07]
A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders. [2005.05]
A randomized, multicenter study comparing the efficacy of recombinant FSH vs recombinant FSH with Ganirelix during superovulation/IUI therapy. [2004.08]
Clinical Trials Related to Ganirelix
A Comparison of the Microdose Leuprolide Protocol vs. Luteal Phase Ganirelix Protocol in Women Who Are or Who Are Predicted to be Low Responders [Recruiting]
Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women [Recruiting]
The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium Concentration [Recruiting]
Compromised Microcirculation in Women With Polycystic Ovary Syndrome [Recruiting]
Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation [Recruiting]
|